Early steroid withdrawal in repeat kidney transplantation

Muhammad Mujtaba, Tim E. Taber, William C. Goggins, Muhammad S. Yaqub, Dennis P. Mishler, Martin L. Milgrom, Jonathan A. Fridell, Andrew Lobashevsky, John A. Powelson, Asif A. Sharfuddin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background and objectives: Kidney re-transplantation (KRT) candidates are considered at high risk for graft failure. Most of these patients are kept on a chronic steroid maintenance (CSM) regimen. The safety of early steroid withdrawal (ESW) remains unanswered in KRT. Design, setting, participants, & measurements: This study was aimed at comparing the outcomes of ESW and CSM in KRT. Retrospective analysis of 113 KRT patients (ESW, n = 59; CSM, n = 54) was performed. All patients received rabbit anti-thymocyte globulin/steroid induction and were maintained on mycophenolate/tacrolimus (±steroids). Results: One- and 5-year patient survival for the ESW and the CSM group were not significantly different (98 versus 96% and 91 versus 88%, respectively; P = 0.991). No significant difference was seen in the graft survival for both groups at 1 and 5 years (98 versus 93% and 80 versus 74%, respectively; P = 0.779). Mean 1- and 5-year estimated GFR was not statistically different between the groups (P = 0.773 and 0.790, respectively). The incidence of acute rejection at 1 year was 17 and 22% in ESW and CSM patients, respectively (P = 0.635). Compared with the ESW group, patients in the CSM group were more likely to be hyperlipidemic (P = 0.044), osteoporotic (P = 0.010), post-transplant diabetics (P = 0.051) and required more medications to control BP (P = 0.004). Conclusions: ESW seems to be a reasonable approach in KRT recipients because the short and intermediate patient survival, graft survival, and graft function is comparable to CSM immunosuppression.

Original languageEnglish (US)
Pages (from-to)404-411
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume6
Issue number2
DOIs
StatePublished - Feb 1 2011
Externally publishedYes

Fingerprint

Kidney Transplantation
Steroids
Maintenance
Graft Survival
Transplants
Antilymphocyte Serum
Survival
Tacrolimus
Immunosuppression

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Mujtaba, M., Taber, T. E., Goggins, W. C., Yaqub, M. S., Mishler, D. P., Milgrom, M. L., ... Sharfuddin, A. A. (2011). Early steroid withdrawal in repeat kidney transplantation. Clinical Journal of the American Society of Nephrology, 6(2), 404-411. https://doi.org/10.2215/CJN.05110610

Early steroid withdrawal in repeat kidney transplantation. / Mujtaba, Muhammad; Taber, Tim E.; Goggins, William C.; Yaqub, Muhammad S.; Mishler, Dennis P.; Milgrom, Martin L.; Fridell, Jonathan A.; Lobashevsky, Andrew; Powelson, John A.; Sharfuddin, Asif A.

In: Clinical Journal of the American Society of Nephrology, Vol. 6, No. 2, 01.02.2011, p. 404-411.

Research output: Contribution to journalArticle

Mujtaba, M, Taber, TE, Goggins, WC, Yaqub, MS, Mishler, DP, Milgrom, ML, Fridell, JA, Lobashevsky, A, Powelson, JA & Sharfuddin, AA 2011, 'Early steroid withdrawal in repeat kidney transplantation', Clinical Journal of the American Society of Nephrology, vol. 6, no. 2, pp. 404-411. https://doi.org/10.2215/CJN.05110610
Mujtaba, Muhammad ; Taber, Tim E. ; Goggins, William C. ; Yaqub, Muhammad S. ; Mishler, Dennis P. ; Milgrom, Martin L. ; Fridell, Jonathan A. ; Lobashevsky, Andrew ; Powelson, John A. ; Sharfuddin, Asif A. / Early steroid withdrawal in repeat kidney transplantation. In: Clinical Journal of the American Society of Nephrology. 2011 ; Vol. 6, No. 2. pp. 404-411.
@article{27f9cb223fa34eeca318a8e31a3b3734,
title = "Early steroid withdrawal in repeat kidney transplantation",
abstract = "Background and objectives: Kidney re-transplantation (KRT) candidates are considered at high risk for graft failure. Most of these patients are kept on a chronic steroid maintenance (CSM) regimen. The safety of early steroid withdrawal (ESW) remains unanswered in KRT. Design, setting, participants, & measurements: This study was aimed at comparing the outcomes of ESW and CSM in KRT. Retrospective analysis of 113 KRT patients (ESW, n = 59; CSM, n = 54) was performed. All patients received rabbit anti-thymocyte globulin/steroid induction and were maintained on mycophenolate/tacrolimus (±steroids). Results: One- and 5-year patient survival for the ESW and the CSM group were not significantly different (98 versus 96{\%} and 91 versus 88{\%}, respectively; P = 0.991). No significant difference was seen in the graft survival for both groups at 1 and 5 years (98 versus 93{\%} and 80 versus 74{\%}, respectively; P = 0.779). Mean 1- and 5-year estimated GFR was not statistically different between the groups (P = 0.773 and 0.790, respectively). The incidence of acute rejection at 1 year was 17 and 22{\%} in ESW and CSM patients, respectively (P = 0.635). Compared with the ESW group, patients in the CSM group were more likely to be hyperlipidemic (P = 0.044), osteoporotic (P = 0.010), post-transplant diabetics (P = 0.051) and required more medications to control BP (P = 0.004). Conclusions: ESW seems to be a reasonable approach in KRT recipients because the short and intermediate patient survival, graft survival, and graft function is comparable to CSM immunosuppression.",
author = "Muhammad Mujtaba and Taber, {Tim E.} and Goggins, {William C.} and Yaqub, {Muhammad S.} and Mishler, {Dennis P.} and Milgrom, {Martin L.} and Fridell, {Jonathan A.} and Andrew Lobashevsky and Powelson, {John A.} and Sharfuddin, {Asif A.}",
year = "2011",
month = "2",
day = "1",
doi = "10.2215/CJN.05110610",
language = "English (US)",
volume = "6",
pages = "404--411",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - Early steroid withdrawal in repeat kidney transplantation

AU - Mujtaba, Muhammad

AU - Taber, Tim E.

AU - Goggins, William C.

AU - Yaqub, Muhammad S.

AU - Mishler, Dennis P.

AU - Milgrom, Martin L.

AU - Fridell, Jonathan A.

AU - Lobashevsky, Andrew

AU - Powelson, John A.

AU - Sharfuddin, Asif A.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Background and objectives: Kidney re-transplantation (KRT) candidates are considered at high risk for graft failure. Most of these patients are kept on a chronic steroid maintenance (CSM) regimen. The safety of early steroid withdrawal (ESW) remains unanswered in KRT. Design, setting, participants, & measurements: This study was aimed at comparing the outcomes of ESW and CSM in KRT. Retrospective analysis of 113 KRT patients (ESW, n = 59; CSM, n = 54) was performed. All patients received rabbit anti-thymocyte globulin/steroid induction and were maintained on mycophenolate/tacrolimus (±steroids). Results: One- and 5-year patient survival for the ESW and the CSM group were not significantly different (98 versus 96% and 91 versus 88%, respectively; P = 0.991). No significant difference was seen in the graft survival for both groups at 1 and 5 years (98 versus 93% and 80 versus 74%, respectively; P = 0.779). Mean 1- and 5-year estimated GFR was not statistically different between the groups (P = 0.773 and 0.790, respectively). The incidence of acute rejection at 1 year was 17 and 22% in ESW and CSM patients, respectively (P = 0.635). Compared with the ESW group, patients in the CSM group were more likely to be hyperlipidemic (P = 0.044), osteoporotic (P = 0.010), post-transplant diabetics (P = 0.051) and required more medications to control BP (P = 0.004). Conclusions: ESW seems to be a reasonable approach in KRT recipients because the short and intermediate patient survival, graft survival, and graft function is comparable to CSM immunosuppression.

AB - Background and objectives: Kidney re-transplantation (KRT) candidates are considered at high risk for graft failure. Most of these patients are kept on a chronic steroid maintenance (CSM) regimen. The safety of early steroid withdrawal (ESW) remains unanswered in KRT. Design, setting, participants, & measurements: This study was aimed at comparing the outcomes of ESW and CSM in KRT. Retrospective analysis of 113 KRT patients (ESW, n = 59; CSM, n = 54) was performed. All patients received rabbit anti-thymocyte globulin/steroid induction and were maintained on mycophenolate/tacrolimus (±steroids). Results: One- and 5-year patient survival for the ESW and the CSM group were not significantly different (98 versus 96% and 91 versus 88%, respectively; P = 0.991). No significant difference was seen in the graft survival for both groups at 1 and 5 years (98 versus 93% and 80 versus 74%, respectively; P = 0.779). Mean 1- and 5-year estimated GFR was not statistically different between the groups (P = 0.773 and 0.790, respectively). The incidence of acute rejection at 1 year was 17 and 22% in ESW and CSM patients, respectively (P = 0.635). Compared with the ESW group, patients in the CSM group were more likely to be hyperlipidemic (P = 0.044), osteoporotic (P = 0.010), post-transplant diabetics (P = 0.051) and required more medications to control BP (P = 0.004). Conclusions: ESW seems to be a reasonable approach in KRT recipients because the short and intermediate patient survival, graft survival, and graft function is comparable to CSM immunosuppression.

UR - http://www.scopus.com/inward/record.url?scp=79951916396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951916396&partnerID=8YFLogxK

U2 - 10.2215/CJN.05110610

DO - 10.2215/CJN.05110610

M3 - Article

VL - 6

SP - 404

EP - 411

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 2

ER -